Cataract Awareness Month shone a spotlight on one of the world’s leading causes of vision impairment – which is also one of the most treatable.
With more than 65 million people affected globally and demand for cataract surgery continuing to rise as populations age, delivering timely, high-quality care has never been more important.
While cataract surgery is the most common operation performed in the UK, achieving the best possible outcomes depends on much more than the operation itself. Every stage of the patient journey – from early diagnosis and accurate surgical planning to treatment and post-operative recovery – plays a vital role in restoring vision and enhancing quality of life.
Within EssilorLuxottica, innovation is helping to connect every step of that journey. By combining elements such as advanced diagnostic imaging from Heidelberg Engineering, surgical technologies and clinical expertise at Optegra and Signifeye, and ocular surface management from Espansione Group, the entire EssilorLuxottica network is supporting clinicians to deliver more personalised care and better visual outcomes for patients.
You can read the full article to explore how EssilorLuxottica is helping shape the future of cataract care through an integrated approach that benefits both healthcare professionals and the millions of people worldwide living with cataracts.
